Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab plus nivolumab in advanced nonclear cell renal cell carcinoma.

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 1|浏览20
暂无评分
关键词
renal cell carcinomafinal,rare variant renal cell,nivolumab,sequential immunotherapy,carcinomafinal report
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要